TY - JOUR
T1 - A genotype-first approach for the molecular and clinical characterization of uncommon de novo microdeletion of 20q13.33
AU - Traylor, Ryan N.
AU - Bruno, Damien L.
AU - Burgess, Trent
AU - Wildin, Robert
AU - Spencer, Anne
AU - Ganesamoorthy, Devika
AU - Amor, David J.
AU - Hunter, Matthew
AU - Caplan, Michael
AU - Rosenfeld, Jill A.
AU - Theisen, Aaron
AU - Torchia, Beth S.
AU - Shaffer, Lisa G.
AU - Ballif, Blake C.
AU - Slater, Howard R.
PY - 2010
Y1 - 2010
N2 - Background: Subtelomeric deletions of the long arm of chromosome 20 are rare, with only 11 described in the literature. Clinical features of individuals with these microdeletions include severe limb malformations, skeletal abnormalities, growth retardation, developmental and speech delay, mental retardation, seizures and mild, non-specific dysmorphic features. Methodology/Principal Findings: We characterized microdeletions at 20q13.33 in six individuals referred for genetic evaluation of developmental delay, mental retardation, and/or congenital anomalies. A comparison to previously reported cases of 20q13.33 microdeletion shows phenotypic overlap, with clinical features that include mental retardation, developmental delay, speech and language deficits, seizures, and behavior problems such as autistic spectrum disorder. There does not appear to be a clinically recognizable constellation of dysmorphic features among individuals with subtelomeric 20q microdeletions. Conclusions/Significance: Based on genotype-phenotype correlation among individuals in this and previous studies, we discuss several possible candidate genes for specific clinical features, including ARFGAP1, CHRNA4 and KCNQ2 and neurodevelopmental deficits. Deletion of this region may play an important role in cognitive development.
AB - Background: Subtelomeric deletions of the long arm of chromosome 20 are rare, with only 11 described in the literature. Clinical features of individuals with these microdeletions include severe limb malformations, skeletal abnormalities, growth retardation, developmental and speech delay, mental retardation, seizures and mild, non-specific dysmorphic features. Methodology/Principal Findings: We characterized microdeletions at 20q13.33 in six individuals referred for genetic evaluation of developmental delay, mental retardation, and/or congenital anomalies. A comparison to previously reported cases of 20q13.33 microdeletion shows phenotypic overlap, with clinical features that include mental retardation, developmental delay, speech and language deficits, seizures, and behavior problems such as autistic spectrum disorder. There does not appear to be a clinically recognizable constellation of dysmorphic features among individuals with subtelomeric 20q microdeletions. Conclusions/Significance: Based on genotype-phenotype correlation among individuals in this and previous studies, we discuss several possible candidate genes for specific clinical features, including ARFGAP1, CHRNA4 and KCNQ2 and neurodevelopmental deficits. Deletion of this region may play an important role in cognitive development.
UR - http://www.scopus.com/inward/record.url?scp=77957909505&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0012462
DO - 10.1371/journal.pone.0012462
M3 - Article
C2 - 20805988
AN - SCOPUS:77957909505
VL - 5
JO - PLoS ONE
JF - PLoS ONE
IS - 8
M1 - e12462
ER -